Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$429.20-0.2%$448.56$408.42▼$623.60$6.27B0.43205,188 shs135,036 shsDGXQuest Diagnostics$182.81-0.7%$181.42$146.91▼$191.49$20.58B0.56857,833 shs809,280 shsDVADaVita$123.89-0.1%$132.95$122.93▼$179.60$8.87B1.13817,079 shs455,133 shsLHLabcorp$276.37-0.5%$275.56$209.38▼$289.20$23.09B0.89555,952 shs383,645 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed-0.03%-1.34%-3.77%-5.56%-27.24%DGXQuest Diagnostics-0.80%+2.40%-0.03%+9.87%+22.96%DVADaVita-0.02%-3.34%-6.91%-11.81%-22.98%LHLabcorp-0.57%+0.39%-0.61%+12.47%+27.72%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$429.20-0.2%$448.56$408.42▼$623.60$6.27B0.43205,188 shs135,036 shsDGXQuest Diagnostics$182.81-0.7%$181.42$146.91▼$191.49$20.58B0.56857,833 shs809,280 shsDVADaVita$123.89-0.1%$132.95$122.93▼$179.60$8.87B1.13817,079 shs455,133 shsLHLabcorp$276.37-0.5%$275.56$209.38▼$289.20$23.09B0.89555,952 shs383,645 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed-0.03%-1.34%-3.77%-5.56%-27.24%DGXQuest Diagnostics-0.80%+2.40%-0.03%+9.87%+22.96%DVADaVita-0.02%-3.34%-6.91%-11.81%-22.98%LHLabcorp-0.57%+0.39%-0.61%+12.47%+27.72%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 2.80Moderate Buy$578.5034.79% UpsideDGXQuest Diagnostics 2.53Moderate Buy$186.632.09% UpsideDVADaVita 1.80Reduce$155.2525.31% UpsideLHLabcorp 2.71Moderate Buy$292.005.66% UpsideCurrent Analyst Ratings BreakdownLatest DVA, DGX, LH, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/9/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$160.00 ➝ $149.0010/8/2025CHEChemedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025DGXQuest DiagnosticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)10/8/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$185.00 ➝ $190.0010/8/2025DVADaVitaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/8/2025LHLabcorpWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B-)10/3/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$300.00 ➝ $305.0010/2/2025DGXQuest DiagnosticsBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$185.00 ➝ $190.0010/2/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$275.00 ➝ $290.009/27/2025CHEChemedWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025DGXQuest DiagnosticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B2.57$25.65 per share16.73$74.35 per share5.77DGXQuest Diagnostics$9.87B2.07$13.41 per share13.63$61.38 per share2.98DVADaVita$12.82B0.69$19.12 per share6.48$4.83 per share25.65LHLabcorp$13.01B1.77$22.29 per share12.40$96.27 per share2.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$19.4522.0718.422.5011.56%25.83%17.77%10/28/2025 (Confirmed)DGXQuest Diagnostics$871M$8.3521.8917.432.449.01%15.24%6.64%10/21/2025 (Estimated)DVADaVita$936.34M$10.1712.189.750.896.35%369.39%4.62%11/4/2025 (Estimated)LHLabcorp$746M$9.0630.5015.761.785.66%15.45%7.02%10/28/2025 (Estimated)Latest DVA, DGX, LH, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025DVADaVita$3.29N/AN/AN/AN/AN/A10/28/2025Q3 2025CHEChemed$5.39N/AN/AN/A$626.04 millionN/A10/28/2025Q3 2025LHLabcorp$4.12N/AN/AN/A$3.56 billionN/A10/21/2025Q3 2025DGXQuest Diagnostics$2.51N/AN/AN/A$2.73 billionN/A8/5/2025Q2 2025DVADaVita$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion7/29/2025Q2 2025CHEChemed$6.02$4.27-$1.75$3.57$650.60 million$618.80 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.400.56%N/A12.34%16 YearsDGXQuest Diagnostics$3.201.75%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.04%N/A31.79%N/ALatest DVA, DGX, LH, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date10/8/2025LHLabcorpquarterly$0.721.04%11/26/202511/26/202512/11/20258/13/2025DGXQuest Diagnosticsquarterly$0.801.79%10/3/202510/3/202510/20/20258/1/2025CHEChemedquarterly$0.600.6%8/11/20258/11/20258/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.861.83DGXQuest Diagnostics0.711.090.99DVADaVitaN/A1.391.34LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita1.50%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.57 million14.09 millionOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00071.50 million70.43 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableDGX, LH, DVA, and CHE HeadlinesRecent News About These CompaniesAberdeen Group plc Purchases 3,599 Shares of Labcorp Holdings Inc. $LH1 hour ago | marketbeat.comSequoia Financial Advisors LLC Acquires 1,816 Shares of Labcorp Holdings Inc. $LHOctober 13 at 5:32 AM | marketbeat.comLabcorp Holdings Inc. $LH Shares Sold by Stack Financial Management IncOctober 13 at 5:14 AM | marketbeat.comAllspring Global Investments Holdings LLC Has $528.74 Million Position in Labcorp Holdings Inc. $LHOctober 13 at 5:06 AM | marketbeat.comBoard of the Pension Protection Fund Purchases New Position in Labcorp Holdings Inc. $LHOctober 12 at 5:55 AM | marketbeat.comGalvin Gaustad & Stein LLC Sells 74,638 Shares of Labcorp Holdings Inc. $LHOctober 11 at 4:42 AM | marketbeat.comLeerink Partnrs Has Positive Outlook for Labcorp Q3 EarningsOctober 11 at 2:17 AM | americanbankingnews.com3 Medical Service Industry Stocks Poised to Counter Workforce IssuesOctober 10, 2025 | zacks.comQ3 Earnings Estimate for Labcorp Issued By Leerink PartnrsOctober 10, 2025 | marketbeat.comLabcorp (NYSE:LH) Earns "Buy (B-)" Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comLabcorp (LH) Upgraded to Buy: What Does It Mean for the Stock?October 9, 2025 | zacks.comWhy Labcorp Holdings (LH) is a Top Growth Stock for the Long-TermOctober 9, 2025 | zacks.comLabcorp Holdings Declares Cash Dividend AnnouncementOctober 9, 2025 | msn.comLabcorp Holdings Inc. (NYSE:LH) Announces $0.72 Quarterly DividendOctober 8, 2025 | marketbeat.comLabcorp Declares Quarterly DividendOctober 8, 2025 | prnewswire.comLabcorp Holdings’ Q3 2025 Earnings: What to ExpectOctober 8, 2025 | msn.comNavera Investment Management Ltd. Lowers Position in Labcorp Holdings Inc. $LHOctober 8, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Sells 7,203 Shares of Labcorp Holdings Inc. $LHOctober 8, 2025 | marketbeat.comQRG Capital Management Inc. Lowers Position in Labcorp Holdings Inc. $LHOctober 7, 2025 | marketbeat.com1 Healthcare Stock with Exciting Potential and 2 Facing ChallengesOctober 6, 2025 | finance.yahoo.comHunter Perkins Capital Management LLC Sells 8,292 Shares of Labcorp Holdings Inc. $LHOctober 6, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy Wall Street Is Betting Billions on Oklo's Nuclear VisionBy Jeffrey Neal Johnson | September 26, 2025Can Advantage2 Help Overcome D-Wave's Share Price Plateau?By Nathan Reiff | September 18, 2025General Mills Is a Generational Opportunity for Income InvestorsBy Thomas Hughes | September 18, 2025Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It ComingBy Dan Schmidt | September 24, 20253 Automation-Focused Stocks Flying Under the RadarBy Nathan Reiff | September 22, 2025DGX, LH, DVA, and CHE Company DescriptionsChemed NYSE:CHE$429.20 -0.82 (-0.19%) Closing price 10/13/2025 03:59 PM EasternExtended Trading$429.44 +0.25 (+0.06%) As of 10/13/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$182.81 -1.26 (-0.68%) Closing price 10/13/2025 03:59 PM EasternExtended Trading$182.72 -0.09 (-0.05%) As of 10/13/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$123.89 -0.10 (-0.08%) Closing price 10/13/2025 03:59 PM EasternExtended Trading$123.90 +0.01 (+0.01%) As of 10/13/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$276.37 -1.51 (-0.54%) Closing price 10/13/2025 03:59 PM EasternExtended Trading$289.02 +12.66 (+4.58%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise D-Wave: Reevaluating the Short Seller’s Case After the Downgrade 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Applied Digital’s Shorts Got Squeezed—Now What? Levi Strauss Stock Set to Reach New Highs in 2026 Alphabet: The AI Powerhouse Driving Markets Into 2026 Is the Reddit-ChatGPT Love Affair Over? Broadcom Gets Second $420 Target as CPO Win Boosts Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
